Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shigematsu Works CoTSE:7980 -1.33%78 Return-on-Tangible-Equity is 16.72% as of Mar. 2026, which is 108% above its 10-year median of 8.02. GuruFocus rates TSE:7980 with a GF Score™ of 78/100 and a GF Value™ of 円947.99 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Shigematsu Works Co ranks better than 61.66% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Shigematsu Works Co's annualized net income for the quarter that ended in Mar. 2026 was 円1,432 Mil. Shigematsu Works Co's average shareholder tangible equity for the quarter that ended in Mar. 2026 was 円8,564 Mil. Therefore, Shigematsu Works Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 16.72%.
The historical rank and industry rank for Shigematsu Works Co's Return-on-Tangible-Equity or its related term are showing as below:
TSE:7980'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 1 Med: 8.02 Max: 12.67
Current: 8.4
During the past 13 years, Shigematsu Works Co's highest Return-on-Tangible-Equity was 12.67%. The lowest was 1.00%. And the median was 8.02%.
TSE:7980's Return-on-Tangible-Equity is ranked better than 61.66% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 4.04
vs TSE:7980: 8.40
Shigematsu Works Co (TSE:7980) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Shigematsu Works Co Return-on-Tangible-Equity Related Terms
Shigematsu Works Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Shigematsu Works Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shigematsu Works Co Return-on-Tangible-Equity Chart
TSE:7980 vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Shigematsu Works Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shigematsu Works Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shigematsu Works Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Shigematsu Works Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 16.72% mean?
Shigematsu Works Co (TSE:7980) has a Return-on-Tangible-Equity of 16.72% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Shigematsu Works Co and its competitors. This is 108% above median its historical median of 8.02. Over the past decade, Shigematsu Works Co's Return-on-Tangible-Equity has ranged from 1.00 to 12.67. According to the industry distribution chart, Shigematsu Works Co ranks #291 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 38.3%.
Is Shigematsu Works Co's Return-on-Tangible-Equity too high?
Shigematsu Works Co's current Return-on-Tangible-Equity of 16.72% is 108% above median its 10-year median of 8.02. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 12.67. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.04. Shigematsu Works Co's value of 16.72% is 313.9% above this industry median. Based on the distribution chart, Shigematsu Works Co ranks #291 out of 759 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shigematsu Works Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shigematsu Works Co's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shigematsu Works Co ranks #291 out of 759 companies for Return-on-Tangible-Equity. This puts Shigematsu Works Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.04. Shigematsu Works Co's value of 16.72% is 313.9% above this benchmark. Historically, Shigematsu Works Co's own Return-on-Tangible-Equity has ranged from 1.00 to 12.67 over the past decade. While the company's 10-year median is 8.02 vs. the industry median of 4.04, Shigematsu Works Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.04, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shigematsu Works Co's current Return-on-Tangible-Equity of 16.72% is 313.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Shigematsu Works Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shigematsu Works Co's current Return-on-Tangible-Equity is 16.72%, which is 108% above median its own 10-year median of 8.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shigematsu Works Co stock overvalued right now?
Based on GuruFocus' analysis, Shigematsu Works Co (TSE:7980) is currently considered Modestly Undervalued. The stock's GF Value™ is 円947.99, compared to a current price of 円813.00 — trading 14.2% below its estimated fair value. The current Return-on-Tangible-Equity is 16.72%, which is 108% above median its 10-year median of 8.02 and 313.9% above the Medical Devices & Instruments industry median of 4.04. Shigematsu Works Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Shigematsu Works Co (TSE:7980), the current Return-on-Tangible-Equity is 16.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shigematsu Works Co (TSE:7980) Overvalued in 2026?
Based on GuruFocus' analysis, Shigematsu Works Co stock appears to be undervalued.
The current stock price of 円813.00 is trading 14.2% below its estimated GF Value™ of 円947.99.
GuruFocus considers Shigematsu Works Co to be Modestly Undervalued.
Key valuation signals for TSE:7980:
Return-on-Tangible-Equity: 16.72% (108% above median its 10-year median of 8.02)
GF Value™: 円947.99 vs. price of 円813.00 (14.2% below fair value)
Industry Position: 313.9% above the Medical Devices & Instruments median (#291 of 759)
No single metric tells the full story. See the TSE:7980 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shigematsu Works Co Ltd is a Japan based company engaged in the safety business. It manufactures personal and respiratory protective devices related to fire and industrial safety, equipment for air purifying, emergency and rescue operations. The company offers products such as gas respirators, chemical cartridge respirators, particulate respirators, self-contained breathing apparatus, powered air-purifying respirators, supplied-air respirators, eye protector, face shields, earmuffs, safety belts, protective clothing, protective gloves, stretchers, oxygen meters and other related products. The products offered by the organization has application in various industries including textile, chemical, automobile, fishery, mining, warehouse and others.
78GF Score
Get the complete analysis for TSE:7980
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7980 has been successfully added to your 
